Back to Search
ANNE EVINS, MD
MD
Psychiatry Physician
NPI: 1952334559IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
78405(MA)
CMS Specialties
PrimaryPSYCHIATRY
Education
OTHER
Class of 1991
Research & Publications (20)
Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia.
PMID 18548234·Psychopharmacology (Berl)·2008
2-rct
A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
PMID 19011435·J Clin Psychopharmacol·2008
2-rct
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
PMID 17632223·J Clin Psychopharmacol·2007
2-rct
Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.
PMID 16187778·J Clin Psychiatry·2005
4-observational
A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia.
PMID 15876899·J Clin Psychopharmacol·2005
3-trial
Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction.
PMID 15096068·J Clin Psychiatry·2004
3-trial
Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders.
PMID 12892536·J Clin Psychiatry·2003
4-observational
D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia.
PMID 12084415·Schizophr Res·2002
3-trial
A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.
PMID 11694208·Nicotine Tob Res·2001
3-trial
Placebo-controlled trial of glycine added to clozapine in schizophrenia.
PMID 10784481·Am J Psychiatry·2000
3-trial
Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia.
PMID 19283774·Hum Psychopharmacol·2009
3-trial
Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.
PMID 19512978·J Clin Psychopharmacol·2009
2-rct
Oral glycine administration increases brain glycine/creatine ratios in men: a proton magnetic resonance spectroscopy study.
PMID 19556112·Psychiatry Res·2009
3-trial
A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia.
PMID 19183127·Acta Psychiatr Scand·2009
4-observational
A placebo-controlled study of sildenafil effects on cognition in schizophrenia.
PMID 18716761·Psychopharmacology (Berl)·2009
2-rct
Single dose of a dopamine agonist impairs reinforcement learning in humans: evidence from event-related potentials and computational modeling of striatal-cortical function.
PMID 18726908·Hum Brain Mapp·2009
2-rct
Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine.
PMID 19625881·J Psychiatr Pract·2009
8-other
Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study.
PMID 18799288·Schizophr Res·2008
4-observational
Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse?
PMID 18940597·Neuron·2008
4-observational
Predictors of early abstinence in smokers with schizophrenia.
PMID 19026259·J Clin Psychiatry·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 25 STANIFORD STREET, 2ND FLOOR
BOSTON, MA 02114 - Phone
- (617) 912-7800
Quick Facts
- NPI
- 1952334559
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile